Study for Consolidation Period of Chronic Hepatitis B

NCT01732354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2018-04-19

No results posted yet for this study

Summary

The investigators aim to clarify the issue of adequate duration of consolidation period of Chronic hepatitis B infection with antiviral treatment with Tenofovir which could strike a balance between durable HBeAg seroconversion and avoiding long-term inevitable serological or virological recurrence.

Conditions

Sponsors & Collaborators

  • Tainan Municipal Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-11-20
Completion
2018-04-18

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01732354 on ClinicalTrials.gov